-
Depression Among Rheumatoid Arthritis Patients Using the Medical Expenditure Panel Survey Database
Mar 10, 2025, 14:00 PM -
Development of Robust Comprehensive Code Lists to Ensure Consistency Across Global Real-World Evidence Studies
Mar 10, 2025, 14:00 PM -
Training and Validation of CARAaiTM: A Multi LLM Platform and Data Model to Address Oncology-Specific Challenges in Clinical Data Extraction
Mar 10, 2025, 14:00 PM -
An Economic Model to Evaluate the Impact of Formulary Tier Increases for Apixaban on the Incidence and Cost of Clinical Events in Patients with Non-Valvular Atrial Fibrillation in the United States
Mar 10, 2025, 14:00 PM -
Estimated Impact of Pre-Exposure Prophylaxis for COVID-19 on Quality of Life and Physical Distancing Among Immunocompromised Individuals and Caregivers
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization by Severity of Disease Among Adult Patients With Asthma in the United States
Mar 10, 2025, 14:00 PM -
Contemporary Treatment Patterns of Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Analysis of German Claims Data
Mar 10, 2025, 14:00 PM -
Obesity Impact on Incidence of Chronic Comorbid Conditions
Mar 10, 2025, 14:00 PM -
Evaluating PICOs Requested by Member States During Scoping for EU HTA Versus Those Covered in Actual HTAs
Mar 10, 2025, 14:00 PM -
Assessing the Completeness of Oncology Treatment Data from Administrative Claims: A Benchmarking Study Against Abstracted EHRs Using Patient-Level Linkages
Mar 10, 2025, 14:00 PM -
Estimating Healthcare Resource Utilization and Direct Costs of Chronic Myeloid Leukemia in the Brazilian Public Health System
Mar 10, 2025, 14:00 PM -
Budget Impact Analysis of Lanadelumab Versus C1 Inhibitor for Hereditary Angioedema Long Term Prophylaxis: A Brazilian Private Sector Perspective
Mar 10, 2025, 14:00 PM -
Treatment Patterns Post-CAR T Cell Therapy in Patients With Hematologic Malignancies: A Real-World US Study
Mar 10, 2025, 14:00 PM -
Overall Survival in People Living with HIV, Who Experienced Progressive Multifocal Leukoencephalopathy
Mar 10, 2025, 14:00 PM -
Evaluation of Chronic Conditions and Severe Outcomes in Adults Aged 18-59 Years With Medically Attended RSV Illness Using U.S. Commercial Claims Data
Mar 10, 2025, 14:00 PM -
Relationship Between Event-Free Survival (EFS) and Overall Survival (OS) in Newly Diagnosed Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)
Mar 10, 2025, 14:00 PM -
Characterization of Patients With Desmoid Tumors (DT) and Their Treatment Patterns Within an Academic Health System in the United States
Mar 10, 2025, 14:00 PM -
Development and Validation of a Claims-Based Approach to Identify Patients with Metastatic Triple Negative Breast Cancer (mTNBC)
Mar 10, 2025, 14:00 PM -
Variation in Provider Reimbursement for Biosimilars and Reference Biologics by Commercial Payers
Mar 10, 2025, 14:00 PM -
Evaluating the ICER Special Report in the Context of Medicare Drug Price Negotiations: Implications for Manufacturer Pricing and Evidence Strategies
Mar 10, 2025, 14:00 PM